Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Okabe M et al. | Competence effect of PDGF on Ki-67 antigen and DNA contents, and its inhibition by trichostatin-A and a butylydene phthalide BP-421 in primary smooth muscle cells of rat aorta by flow cytometry. | 1995 | Biol. Pharm. Bull. | pmid:8787785 |
Worrad DM et al. | Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. | 1995 | Development | pmid:7555721 |
O'Neill LP and Turner BM | Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. | 1995 | EMBO J. | pmid:7664735 |
Arts J et al. | Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. | 1995 | Biochem. J. | pmid:7646441 |
Almouzni G et al. | Histone acetylation influences both gene expression and development of Xenopus laevis. | 1994 | Dev. Biol. | pmid:7958429 |
Miyashita T et al. | Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. | 1994 | FEBS Lett. | pmid:7523197 |
Kimura M et al. | Dual modes of action of platelet-derived growth factor and its inhibition by trichostatin-A for DNA synthesis in primary cultured smooth muscle cells of rat aorta. | 1994 | Biol. Pharm. Bull. | pmid:8019505 |
Sanchez del Pino MM et al. | Properties of the yeast nuclear histone deacetylase. | 1994 | Biochem. J. | pmid:7980438 |
Hoshikawa Y et al. | Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. | 1994 | Exp. Cell Res. | pmid:8082721 |
Girardot V et al. | Relationship between core histone acetylation and histone H1(0) gene activity. | 1994 | Eur. J. Biochem. | pmid:7925412 |
Kijima M et al. | Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. | 1993 | J. Biol. Chem. | pmid:8226751 |
Sugita K et al. | Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A. | 1992 | Cancer Res. | pmid:1727377 |
Sugita K et al. | A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. | 1992 | Biochem. Biophys. Res. Commun. | pmid:1731795 |
[Isolation of drug-resistant mutant cells]. | 1991 | Tanpakushitsu Kakusan Koso | pmid:1745788 | |
Yoshida M et al. | Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. | 1990 | J. Antibiot. | pmid:2211374 |
Yoshida M et al. | Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. | 1990 | J. Biol. Chem. | pmid:2211619 |
Massa S et al. | Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A. | 1990 | J. Med. Chem. | pmid:2213836 |
Yoshida M and Beppu T | [Trichostatins and leptomycins, new cell cycle inhibitors specific for G1 and G2 phases]. | 1989 | Tanpakushitsu Kakusan Koso | pmid:2678278 |
Yoshida M and Beppu T | Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. | 1988 | Exp. Cell Res. | pmid:3134246 |
Otoguro K et al. | Screening for new antitrichomonal substances of microbial origin and antitrichomonal activity of trichostatin A. | 1988 | J. Antibiot. | pmid:3372352 |
Yoshida M et al. | Effects of trichostatins on differentiation of murine erythroleukemia cells. | 1987 | Cancer Res. | pmid:2439196 |
Corelli F et al. | [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A]. | 1987 | Farmaco Sci | pmid:3329612 |
Mazzio EA and Soliman KFA | Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. | Cancer Genomics Proteomics | pmid:30194076 | |
Rahimian A et al. | [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. | Mol. Biol. (Mosk.) | pmid:29989579 | |
pmid: | ||||
Shin S et al. | Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. | Cancer Genomics Proteomics | pmid:28871002 |